Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Cigna logoCigna CI

The company said capital expenditures for property, equipment and computer software rose to $1.6 billion in 2023 from $1.3 billion in the prior year. It attributed the increase to its continued strategic investment in technology and said it expects to deploy about $1.5 billion in capital expenditures in 2024.

10-KAnnual reportFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said capital expenditures for property, equipment and computer software rose to $1.6 billion in 2023 from $1.3 billion in the prior year. It attributed the increase to its continued strategic investment in technology and said it expects to deploy about $1.5 billion in capital expenditures in 2024.

  2. The Cigna Group said it paid quarterly cash dividends of $1.23 per share in 2023, up from $1.12 per share in 2022. It also said it repurchased 7.8 million shares for about $2.3 billion in 2023 and repurchased 27.4 million shares for about $7.6 billion in 2022.

  3. Cigna said on February 2024 that it entered into accelerated share repurchase agreements with Deutsche Bank AG and Bank of America, N.A. totaling $3.2 billion, remitted $3.2 billion, and received an initial delivery of about 7.6 million shares on February 15, 2024. It said share repurchase authority was $7.3 billion as of February 28, 2024.

  4. The company said it had $5.0 billion of undrawn committed capacity under its revolving credit agreements, $3.8 billion of remaining capacity under its commercial paper program and $8.0 billion in cash and short-term investments as of December 31, 2023. It said about $0.8 billion of that cash and short-term investments was held by the parent company or certain non-regulated subsidiaries.

Key figures

Fiscal year ended December 31, 2023

Revenue
$195.3B
Operating income
$8.5B
EPS
$17.39
Operating cash flow
$11.8B

From the XBRL financial data filed with the SEC · not processed by AI.

Summary

AI-written

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

2023 Capital Expenditures and 2024 Plans

The company said capital expenditures for property, equipment and computer software rose to $1.6 billion in 2023 from $1.3 billion in the prior year. It attributed the increase to its continued strategic investment in technology and said it expects to deploy about $1.5 billion in capital expenditures in 2024.

Source · Based on the MD&A text of the filing

Shareholder Returns: Dividends and Share Repurchases

The Cigna Group said it paid quarterly cash dividends of $1.23 per share in 2023, up from $1.12 per share in 2022. It also said it repurchased 7.8 million shares for about $2.3 billion in 2023 and repurchased 27.4 million shares for about $7.6 billion in 2022.

Source · Based on the MD&A text of the filing

2024 ASR Agreements and Repurchase Authority

Cigna said on February 2024 that it entered into accelerated share repurchase agreements with Deutsche Bank AG and Bank of America, N.A. totaling $3.2 billion, remitted $3.2 billion, and received an initial delivery of about 7.6 million shares on February 15, 2024. It said share repurchase authority was $7.3 billion as of February 28, 2024.

Source · Based on the MD&A text of the filing

Summary of Available Liquidity

The company said it had $5.0 billion of undrawn committed capacity under its revolving credit agreements, $3.8 billion of remaining capacity under its commercial paper program and $8.0 billion in cash and short-term investments as of December 31, 2023. It said about $0.8 billion of that cash and short-term investments was held by the parent company or certain non-regulated subsidiaries.

Source · Based on the MD&A text of the filing

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.